Humacyte Inc (HUMA) Stock Observes 16.41% 200-Day Moving Average
The stock of Humacyte Inc (HUMA) has seen a -9.09% decrease in the past week, with a -31.25% drop in the past month, and a
The stock of Humacyte Inc (HUMA) has seen a -9.09% decrease in the past week, with a -31.25% drop in the past month, and a
The 36-month beta value for HUMA is also noteworthy at 1.47. There are mixed opinions on the stock, with 4 analysts rating it as a
HUMA has 36-month beta value of 1.53. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,”
The stock of Humacyte Inc (HUMA) has gone down by -4.12% for the week, with a 22.64% rise in the past month and a 75.00%
Humacyte Inc (NASDAQ: HUMA) has experienced a decline in its stock price by -4.61 compared to its previous closing price of 8.25. However, the company
The stock has a 36-month beta value of 1.35. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as
Humacyte Inc (NASDAQ: HUMA) has experienced a rise in its stock price by 10.60 compared to its previous closing price of 7.55. However, the company
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.